Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16.

Mikkel Østergaard; L Jacobsson; C Schaufelberger; Michael Sejer Hansen; J Bijlsma; A Dudek; M Rell-Bakalarska; F Staelens; R Haake; E Sundman-Engberg; Henning Bliddal

Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16.

Mikkel Østergaard, L Jacobsson, C Schaufelberger, Michael Sejer Hansen, J Bijlsma, A Dudek, M Rell-Bakalarska, F Staelens, R Haake, E Sundman-Engberg, Henning Bliddal

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	73
Udgave nummer	Suppl. 2
Sider (fra-til)	472
Antal sider	1
ISSN	0003-4967
Status	Udgivet - 2014

Citationsformater

Østergaard, M., Jacobsson, L., Schaufelberger, C., Hansen, M. S., Bijlsma, J., Dudek, A., Rell-Bakalarska, M., Staelens, F., Haake, R., Sundman-Engberg, E., & Bliddal, H. (2014). Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16. Annals of the Rheumatic Diseases, 73(Suppl. 2), 472.

Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16. / Østergaard, Mikkel; Jacobsson, L; Schaufelberger, C et al.
I: Annals of the Rheumatic Diseases, Bind 73, Nr. Suppl. 2, 2014, s. 472.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Østergaard, M, Jacobsson, L, Schaufelberger, C, Hansen, MS, Bijlsma, J, Dudek, A, Rell-Bakalarska, M, Staelens, F, Haake, R, Sundman-Engberg, E & Bliddal, H 2014, 'Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16.', Annals of the Rheumatic Diseases, bind 73, nr. Suppl. 2, s. 472.

Østergaard M, Jacobsson L, Schaufelberger C, Hansen MS, Bijlsma J, Dudek A et al. Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16. Annals of the Rheumatic Diseases. 2014;73(Suppl. 2):472.

Østergaard, Mikkel ; Jacobsson, L ; Schaufelberger, C et al. / Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16. I: Annals of the Rheumatic Diseases. 2014 ; Bind 73, Nr. Suppl. 2. s. 472.

@article{191d54a5951d47eab67886144fe63b36,

title = "Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16.",

author = "Mikkel {\O}stergaard and L Jacobsson and C Schaufelberger and Hansen, {Michael Sejer} and J Bijlsma and A Dudek and M Rell-Bakalarska and F Staelens and R Haake and E Sundman-Engberg and Henning Bliddal",

year = "2014",

language = "English",

volume = "73",

pages = "472",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 2",

}

TY - ABST

T1 - Magnetic Resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16.

AU - Østergaard, Mikkel

AU - Jacobsson, L

AU - Schaufelberger, C

AU - Hansen, Michael Sejer

AU - Bijlsma, J

AU - Dudek, A

AU - Rell-Bakalarska, M

AU - Staelens, F

AU - Haake, R

AU - Sundman-Engberg, E

AU - Bliddal, Henning

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

SN - 0003-4967

VL - 73

SP - 472

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 2

ER -